Japan System Techniques Co.,Ltd. (4323) Stock Price

Japan System Technology operates four major business segments. In the DX & SI business, the company provides information systems across diverse industries, including production management systems for manufacturing, store information systems for distribution, and accounting systems for financial institutions. The company also offers office DX solutions utilizing facial recognition technology and the human resources management service "mieHR."

In the package business, the company develops and sells integrated systems for universities, including the "GAKUEN RX" series and "UNIVERSAL PASSPORT RX." These systems aim to streamline school administration and support decision-making in university management. The company also provides "UNIPAPay," an electronic money issuance and payment platform, as well as cloud infrastructure services for universities.

In the healthcare big data business, the company provides "JMiCS," an automated medical claim review service, and healthcare cost optimization services. These offerings promote the utilization of medical data and support the efficiency of insurance provider operations. The company also provides data health plan implementation support and health promotion services for health insurance associations.

Finally, in the global business, the company develops and sells ERP and HRM products for overseas operations. Through integrated ERP implementation consulting and the cloud-based HRM solution "AGHRM," the company expands IT services in overseas markets. The company also provides offshore development services and custom development of various business applications.

Japan System Technology, as an independent company, is committed to the mission of "contributing to society through the creation and provision of information solutions." The company continues to embrace cutting-edge technology while balancing unwavering core principles with adaptive management to achieve long-term stable growth.

For the fiscal year ending March 2025, the company has set the annual policy of "Connecting JAST DNA to the next 50 years." It is advancing high-value-added business initiatives and building new business models in its DX & SI operations to expand its business domains.

In its package business, the company continues to grow by strengthening the functionality and quality of flagship products, creating new business opportunities, and making strategic research and development investments to enhance brand strength. The medical big data business is also expanding its revenue base.

In global operations, the company is establishing development and sales bases primarily across ASEAN countries, expanding the market reach of its SAP business, and developing and selling new products. These efforts are driving sustained business growth.

The company has formulated "JAST VISION 2035," a vision toward 2035, targeting consolidated net sales of 100 billion yen. Based on this vision, it is currently developing a medium-term management plan for fiscal year 2026 and beyond.